BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 195762)

  • 21. Clonidine-induced locomotor hyperactivity in rats. The role of central postsynaptic alpha-adrenoceptors.
    Zebrowska-Lupina I; Przegalinski E; Sloniec M; Kleinrok Z
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Apr; 297(3):227-31. PubMed ID: 69273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. alpha-Adrenergic agents. 3. Behavioral effects of 2-aminotetralins.
    Holz WC; Hieble JP; Gill CA; DeMarinis RM; Pendleton RG
    Psychopharmacology (Berl); 1982; 77(3):259-67. PubMed ID: 6126908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of apomorphine administration on locomotor activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1983; 14(5):545-7. PubMed ID: 6685669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-response functions of apomorphine, SKF 38393, LY 171555, haloperidol and clonidine on the self-stimulation evoked from lateral hypothalamus and ventral tegmentum.
    Singh J; Desiraju T; Raju TR
    Indian J Physiol Pharmacol; 1996 Jan; 40(1):15-22. PubMed ID: 8864766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on the diuretic effect of haloperidol in adult rats].
    Shirakura Y
    Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):189-97. PubMed ID: 3009287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of brain dopamine as the probable mechanism for the hypothermic effect of D-amphetamine.
    Yehuda S; Wurtman RJ
    Nature; 1972 Dec; 240(5382):477-8. PubMed ID: 4565945
    [No Abstract]   [Full Text] [Related]  

  • 27. Catecholaminergic influences on induced hippocampal paroxysmal activity in rats.
    de Campos CJ; Cavalheiro EA
    Acta Physiol Pharmacol Latinoam; 1986; 36(3):233-49. PubMed ID: 3577804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous activity and apomorphine stereotypy during and after withdrawal from 3 1/2 months continuous administration of haloperidol: some methodological issues.
    Waddington JL; Gamble SJ
    Psychopharmacology (Berl); 1980; 71(1):75-7. PubMed ID: 6779327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supersensitivity to dopaminergic agonists induced by haloperidol.
    Thornburg JE; Moore KE
    Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):23-8. PubMed ID: 1241913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Jejunal-ileal differences in dopaminergic but not alpha-adrenergic antisecretory effects.
    Wahawisan R; Gaginella TS; Wallace LJ
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G332-6. PubMed ID: 2983568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hyperkinetic syndrome following long-term haloperidol treatment: involvement of dopamine and noradrenaline.
    Jackson DM; Dunstan R; Perrington A
    J Neural Transm; 1979; 44(3):175-86. PubMed ID: 571456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dopamine supersensitivity on lateral hypothalamic self-stimulation in rats.
    Ettenberg A; Milner PM
    Pharmacol Biochem Behav; 1977 Dec; 7(6):507-14. PubMed ID: 563603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible peripheral adrenergic and central dopaminergic influences in memory consolidation.
    Gozzani JL; Izquierdo I
    Psychopharmacology (Berl); 1976 Aug; 49(1):109-11. PubMed ID: 822441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulation.
    Dolphin A; Christina M; Sawaya MC; Jenner P; Marsden CD
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Sep; 299(2):167-73. PubMed ID: 909612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of apomorphine administration on rearing activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1984; 15(4):363-5. PubMed ID: 6541605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.
    Gianutsos G; Thornburg JE; Moore KE
    Psychopharmacology (Berl); 1976 Nov; 50(3):225-9. PubMed ID: 826966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of clonidine on locomotor activity in mice.
    Maj J; Sowińska H; Baran L; Kapturkiewicz Z
    Life Sci I; 1972 May; 11(10):483-91. PubMed ID: 4676386
    [No Abstract]   [Full Text] [Related]  

  • 39. BehavioraL and biochemical changes caused by muscimol in mice withdrawN from haloperidol administration.
    Kuruvilla A; Fung YK; Uretsky NJ
    Neuropharmacology; 1982 Sep; 21(9):891-7. PubMed ID: 6890637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced responsiveness of alpha-noradrenergic receptors following discrete electrolytic lesions of the nucleus locus coeruleus: a behavioral demonstration.
    De Carvalho LP; Zornetzer SF
    J Neural Transm; 1982; 53(1):23-37. PubMed ID: 6278074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.